Therapeutic areas: Oncology, Vaccines
Post-COVID restructuring and the $43B Seagen acquisition have fundamentally reshaped Pfizer\
Key products: Padcev, Adcetris, Eliquis, Xeljanz, Prevnar
Post-COVID restructuring and the $43B Seagen acquisition have fundamentally reshaped Pfizer\